Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification
- Written by PR Newswire
 |
- Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets
- With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India
HYDERABAD, India, Dec. 27, 2022 /PRNewswire/ -- Hetero, India's leading pharmaceutical...
